4
Changes in Ownership
Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-23-025335
Options or other derivatives
- Chief Financial Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Shawah Robert G. Chief Financial Officer | 2023-02-13 | Grant or award · Stock Option | +75,000 | 75,000 | D | ||
Loading xslF345X03/tm237745-3_4seq1.xml…